| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.11B | 22.02B | 21.40B | 21.25B | 20.53B | 21.14B |
| Gross Profit | 22.11B | 21.28B | 21.20B | 21.01B | 20.30B | 20.73B |
| EBITDA | 1.15B | 2.12B | 2.72B | 3.33B | 3.21B | 2.64B |
| Net Income | 404.00M | 860.00M | 1.25B | 1.60B | 1.61B | 877.00M |
Balance Sheet | ||||||
| Total Assets | 1.18T | 1.15T | 1.14T | 1.19T | 1.21T | 1.24T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 95.76B | 64.52B | 108.97B | 128.42B | 160.63B |
| Total Debt | 54.07B | 54.46B | 43.34B | 66.05B | 102.52B | 105.81B |
| Total Liabilities | 1.13T | 1.10T | 1.08T | 1.11T | 1.14T | 1.17T |
| Stockholders Equity | 52.30B | 50.70B | 58.65B | 73.77B | 71.32B | 72.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 0.00 | -32.97B | -35.05B | 0.00 |
| Operating Cash Flow | 0.00 | 0.00 | 0.00 | -31.98B | -34.28B | 0.00 |
| Investing Cash Flow | 0.00 | 6.28B | -5.94B | 6.11B | 2.49B | -513.00M |
| Financing Cash Flow | 0.00 | 2.90B | -17.96B | 6.35B | -462.00M | 74.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥94.71B | 1.54 | ― | 3.05% | 8.75% | -12.68% | |
69 Neutral | ¥96.55B | 6.66 | ― | 2.46% | 9.12% | 43.43% | |
69 Neutral | ¥61.77B | 6.31 | ― | 2.34% | -0.97% | 27.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥887.40B | 8.76 | ― | 2.10% | 1.39% | 52.58% | |
65 Neutral | ¥10.55B | 8.64 | ― | 2.74% | 7.74% | -92.49% | |
65 Neutral | ¥222.20B | 10.90 | ― | 2.53% | 7.67% | 11.03% |